-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Pharmagreen Biotech Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2018 to Q4 2022.
- Pharmagreen Biotech Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2022 was $47.4K, a 65.1% decline year-over-year.
- Pharmagreen Biotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $314K, a 21.8% increase from 2021.
- Pharmagreen Biotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $257K, a 54.2% decline from 2020.
- Pharmagreen Biotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $563K, a 30% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)